LON:IXI IXICO (IXI) Share Price, News & Analysis GBX 11.25 -0.95 (-7.79%) As of 10:09 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About IXICO Stock (LON:IXI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IXICO alerts:Sign Up Key Stats Today's Range 11▼ 1250-Day Range 7.51▼ 12.2052-Week Range 6.45▼ 13Volume11,759 shsAverage Volume38,844 shsMarket Capitalization£10.43 millionP/E RatioN/ADividend Yield1.27%Price TargetN/AConsensus RatingN/A Company OverviewIXICO is a fast growing and profitable medical data analytics company, providing data management and advanced analytics to the pharmaceutical clinical trials market. Established in 2004 and listed as a public company in October 2013, IXICO has firmly established itself as a trusted partner to the global pharmaceutical industry developing new therapies for neurological conditions such as Alzheimer’s, Parkinson’s and Huntington’s disease. Our purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience. We will focus on developing and deploying breakthrough data analytics, at scale, through our remote access technology platform, to improve the return on investment in drug development and reduce risk and uncertainty in clinical trials for our pharmaceutical clients. Our integrated technology offering encompasses every stage of clinical drug development through to post marketing surveillance and we continue to invest in infrastructure and innovation to support our ambitious growth strategy. Our competitive advantage is our dedication to address complex unmet clinical research needs by partnering and collaborating with clients and academic partners early in the drug development cycle to identify and validate promising new imaging and digital biomarkers. Read More… Receive IXI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IXICO and its competitors with MarketBeat's FREE daily newsletter. Email Address IXI Stock News HeadlinesIXICO plc Announces Shareholder Name Change NotificationMay 20 at 1:14 PM | tipranks.comSMALL CAP IDEA: Ixico embraces AI for new Alzheimer's treatmentsMay 20 at 3:13 AM | msn.comVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.May 22, 2025 | Porter & Company (Ad)IXICO issues share options post-shareholder approvalFebruary 8, 2025 | msn.comIXICO Issues Share Option Awards to Enhance Strategic GoalsFebruary 7, 2025 | tipranks.comIXICO plc Secures Resolutions at AGM, Strengthening GovernanceJanuary 24, 2025 | tipranks.comIXICO Partners with PETNET Solutions to Enhance Neuroimaging ServicesDecember 16, 2024 | markets.businessinsider.comIXICO Full Year 2024 Earnings: Beats ExpectationsDecember 6, 2024 | finance.yahoo.comSee More Headlines IXI Stock Analysis - Frequently Asked Questions How have IXI shares performed this year? IXICO's stock was trading at GBX 12.50 at the start of the year. Since then, IXI stock has decreased by 10.0% and is now trading at GBX 11.25. View the best growth stocks for 2025 here. How were IXICO's earnings last quarter? IXICO plc (LON:IXI) announced its earnings results on Tuesday, May, 20th. The company reported ($1.11) earnings per share (EPS) for the quarter. IXICO had a negative net margin of 31.10% and a negative trailing twelve-month return on equity of 19.14%. How do I buy shares of IXICO? Shares of IXI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of IXICO own? Based on aggregate information from My MarketBeat watchlists, some other companies that IXICO investors own include BioNTech (BNTX), Benefitfocus (BNFT), Grayscale Bitcoin Trust (GBTC), Motif Bio (MTFB), Pfizer (PFE), Tesla (TSLA) and VEON (VEON). Company Calendar Last Earnings5/20/2025Today5/22/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:IXI CIKN/A Webixico.com Phone+44-20-37637499FaxN/AEmployees89Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (3.86) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-0.38Net Income£-3,576,241.73 Net Margins-31.10% Pretax MarginN/A Return on Equity-19.14% Return on Assets-10.40% Debt Debt-to-Equity Ratio3.32 Current Ratio2.85 Quick Ratio4.90 Sales & Book Value Annual Sales£11.50 million Price / Sales0.91 Cash FlowGBX 5 per share Price / Cash Flow2.25 Book ValueGBX 19.57 per share Price / Book0.57Miscellaneous Outstanding Shares92,668,597Free FloatN/AMarket Cap£10.43 million OptionableNot Optionable Beta0.86 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (LON:IXI) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IXICO plc Please log in to your account or sign up in order to add this asset to your watchlist. Share IXICO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.